Wrapping up its ninth year, CHI’s Immunogenicity and Bioassay Summit was host to industry, academia and regulatory authorities who shared new ways of overcoming immunogenicity and bioassay challenges at 3 co-located conferences, 4 short courses, 2 training seminars and the Bioassays for Immuno-Oncology symposium. Cambridge Healthtech Institute (CHI) would like to thank all the speakers, attendees, sponsors, and exhibitors for their participation. The 2017 summit featured:
- 300 Delegates from 165 Companies
- 75 Scientific Presentations & Case Studies, including FDA
- 25 Poster Presentations
- 20 Countries Represented
- 16 Exhibitors
![]()
